Livogrit Prevents Methionine-Cystine Deficiency Induced Nonalcoholic Steatohepatitis by Modulation of Steatosis and Oxidative Stress in Human Hepatocyte-Derived Spheroid and in Primary Rat Hepatocytes
Authors:
Open Access
- 1 April 2022
- journal article
- research article
- Published by Taylor & Francis in Bioengineered
- Vol. 13 (4) , 10811-10826
Abstract
The prevalence of nonalcoholic steatohepatitis (NASH), characterized by fatty liver, oxidative injury, and inflammation, has considerably increased in the recent years. Due to the complexity of NASH pathogenesis, compounds which can target different mechanisms and stages of NASH development are required. A robust screening model with translational capability is also required to develop therapies targeting NASH. In this study, we used HepG2 spheroids and rat primary hepatocytes to evaluate the potency of Livogrit, a tri-herbal Ayurvedic prescription medicine, as a hepatoprotective agent. NASH was developed in the cells via methionine and cystine-deficient cell culture media. Livogrit at concentration of 30 µg/mL was able to prevent NASH development by decreasing lipid accumulation, ROS production, AST release, NFκB activation and increasing lipolysis, GSH (reduced glutathione), and mitochondrial membrane potential. This study suggests that Livogrit might reduce the lipotoxicity-mediated ROS generation and subsequent production of inflammatory mediators as evident from the increased gene expression of FXR, FGF21, CHOP, CXCL5, and their normalization due to Livogrit treatment. Taken together, Livogrit showed the potential as a multimodal therapeutic formulation capable of attenuating the development of NASH. Our study highlights the potential of Livogrit as a hepatoprotective agent with translational possibilities. Graphical abstractKeywords
Funding Information
- Patanjali Research Foundation Trust, Haridwar, India
This publication has 73 references indexed in Scilit:
- Peroxidized unsaturated fatty acids stimulate Toll-like receptor 4 signaling in endothelial cellsLife Sciences, 2013
- Regulation of NF-B-Induced Inflammatory Signaling by Lipid Peroxidation-Derived AldehydesOxidative Medicine and Cellular Longevity, 2013
- Protective effect of extract of Boerhaavia diffusa and Silybum marianum in combination against fructose induced non-alcoholic fatty liver in ratsInternational Journal of Green Pharmacy, 2013
- Isolation and Primary Culture of Rat Hepatic CellsJournal of Visualized Experiments, 2012
- Mechanisms of Lipotoxicity in NAFLD and Clinical ImplicationsJournal of Pediatric Gastroenterology and Nutrition, 2011
- Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitisEuropean Journal of Gastroenterology & Hepatology, 2011
- Antioxidant Activities and Xanthine Oxidase Inhibitory Effects of Extracts and Main Polyphenolic Compounds Obtained from Geranium sibiricum L.Journal of Agricultural and Food Chemistry, 2010
- Extraction of high quality RNA from polysaccharide matrices using cetlytrimethylammonium bromideBiomaterials, 2010
- Pioglitazone: side effect and safety profileExpert Opinion on Drug Safety, 2009
- Role of sulfur amino acids in controlling nutrient metabolism and cell functions: implications for nutritionBritish Journal of Nutrition, 2008